We are live on ! Find out more
MCM

M28 Capital Management Portfolio holdings

AUM $53.8M
1-Year Est. Return 28.63%
This Fund
S&P 500
This Quarter Est. Return
+19.99%
1 Year Est. Return
+28.63%
3 Year Est. Return
+218.52%
5 Year Est. Return
10 Year Est. Return
AUM
$68M
AUM Growth
+$9.38M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$1.12B
$41.5M 60.97%
5,664,548
IVVD icon
2
Invivyd
IVVD
$180M
$10.2M 14.96%
9,248,250
TGTX icon
3
TG Therapeutics
TGTX
$8.58B
$5.84M 8.58%
161,600
GUTS icon
4
Fractyl Health
GUTS
$123M
$2.95M 4.34%
1,856,117
ARWR icon
5
Arrowhead Research
ARWR
$12.1B
$2.32M 3.42%
67,400
PRQR icon
6
ProQR Therapeutics
PRQR
$243M
$2.17M 3.19%
1,019,498
RCKT icon
7
Rocket Pharmaceuticals
RCKT
$348M
$1.26M 1.85%
385,680
SLN
8
Silence Therapeutics
SLN
$521M
$961K 1.41%
185,100
CRIS icon
9
Curis
CRIS
$9.53M
$865K 1.27%
26,053

Similar funds

M28 Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, M28 Capital Management held 9 positions worth $68M, up 16% from $58.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 0%. M28 Capital Management opened no new positions and made no exits, leaving the 9-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • M28 Capital Management's ten largest holdings make up 100% of its $68M portfolio in Q3 2025.
  • M28 Capital Management opened 0 new positions and closed 0 in Q3 2025.
  • M28 Capital Management's portfolio value rose 16% quarter-over-quarter to $68M.

Based on M28 Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.